New Wave Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
2,427
+522
+27% +$533K 0.79% 31
2026
Q1
$1.75M Buy
1,905
+534
+39% +$541K 0.61% 38
2025
Q4
$1.47M Buy
1,371
+246
+22% +$235K 0.54% 39
2025
Q3
$859K Buy
1,125
+7
+0.6% +$5.21K 0.33% 60
2025
Q2
$872K Sell
1,118
-121
-10% -$94K 0.37% 53
2025
Q1
$1.02M Buy
1,239
+381
+44% +$317K 0.46% 44
2024
Q4
$663K Sell
858
-2
-0.2% -$1.66K 0.27% 57
2024
Q3
$762K Sell
860
-484
-36% -$435K 0.35% 49
2024
Q2
$1.22M Buy
+1,344
New +$1.08M 0.65% 38

Other funds holding LLY

New Wave Wealth Advisors's LLY Position: Q2 2026 in Review

New Wave Wealth Advisors increased its Eli Lilly (LLY) stake by 27% in Q2 2026, buying an estimated $533K and bringing the position to 2,427 shares worth $2.91M. The position accounts for 0.79% of the portfolio, ranked #31.

New Wave Wealth Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New Wave Wealth Advisors held 2,427 shares of Eli Lilly worth $2.91M as of Q2 2026.
  • New Wave Wealth Advisors bought 522 Eli Lilly shares in Q2 2026, an estimated $533K.
  • Eli Lilly made up 0.79% of New Wave Wealth Advisors's portfolio in Q2 2026, its #31 holding.
  • New Wave Wealth Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New Wave Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.